Zhicheng Deng, Zhicheng Deng, Guanghui Chen, Yonghui Shi, Ying Lin, Jiebin Ou, . . . Li Lv. (2022). Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification. Frontiers Media S.A..
Chicago Style (17th ed.) CitationZhicheng Deng, et al. Curcumin and Its Nano-formulations: Defining Triple-negative Breast Cancer Targets Through Network Pharmacology, Molecular Docking, and Experimental Verification. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationZhicheng Deng, et al. Curcumin and Its Nano-formulations: Defining Triple-negative Breast Cancer Targets Through Network Pharmacology, Molecular Docking, and Experimental Verification. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.